Proposed registration of Inactivated Porcine Circovirus Type 1–Type 2 Chimera in the product Relsure PCV

This consultation closed on 24 September 2013.
Consultation period: 
27 August 2013 to 24 September 2013

The APVMA is considering an application for the registration of Relsure PCV and to approve the new active constituent, Inactivated Porcine Circovirus Type 1-Type 2 Chimera. The product is to be registered as an aid in the prevention of Porcine Circovirus Type 2 (PCV2) viraemia, as an aid in the prevention of nasal and faecal shedding, as an aid in the reduction of colonisation, and as an aid in the reduction of lymphoid depletion caused by PCV2 and in the control of PCV-associated disease.

We invite comment from 27 August 2013 to 24 September 2013 on whether the application for registration should be granted.

The APVMA is able to consider comments relating to the legislative grounds for registration, including:

  • occupational health and safety
  • safety and first aid
  • chemistry and manufacture
  • residues
  • environmental fate and toxicity
  • trade
  • efficacy.

For more information, see page 21 of Gazette No. 17 - 27 August 2013.

Please send your written submission by email, post or fax to:

Veterinary Medicines Program
Australian Pesticides and Veterinary Medicines Authority
PO Box 6182
Kingston ACT 2604

Email: vetmedicines@apvma.gov.au
Fax: +61 2 6210 4721

For enquiries, please call +61 2 6210 4701.

To protect your privacy, please do not include contact information in your feedback. If you would like a response, please contact us.